Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-09-01
|
Series: | Experimental Hematology & Oncology |
Online Access: | https://doi.org/10.1186/s40164-024-00559-7 |